A Survey That Evaluated More Than 544 Thousand Samples Revealed a Rare Phenotype in the ABO System, Identified Only in Three People, Showing Novel Mutations and the Need for Extra Care in Cases of Laboratorial Incompatibility
The analysis of more than half a million samples revealed an unknown blood type. The finding was made by researchers from Mahidol University in Thailand, who were investigating discrepancies in the ABO system. The result appeared in three people among 544 thousand tests and was detailed in the journal Transfusion and Apheresis Science.
An Anomaly That Emerged by Accident
The team was not looking for a new phenotype. The initial focus was to understand why incompatibilities arise between direct and reverse tests.
These situations occur when the typing of the red blood cells does not match the typing of the serum. This concerns doctors because it can pose risks in transfusions.
-
Wax notebook falls into latrine 800 years ago, survives intact in Germany and reveals Latin notes that may expose the routine of a high-status medieval merchant.
-
After more than 11 years orbiting Mars, NASA declared the MAVEN probe lost, which disappeared after passing behind the Red Planet in December, began to spin abnormally, depleted its batteries, and never responded to controllers on Earth again.
-
China creates a capsule with artificial intelligence that scans the stomach in just 8 minutes and can reduce costs by up to R$ 1,400, paving the way for a new era of gastrointestinal diagnostics without tubes, sedation, and discomfort for patients.
-
Scientists simulate nuclear fireball in the laboratory and discover a surprise in the radioactive fallout by observing how cesium, uranium, and cerium change when they remain at high temperatures for a longer time.
The research involved 285,450 donor samples and 258,780 patient samples. The specialists from Siriraj Hospital analyzed each case to identify the origin of the discrepancies and observed that they were uncommon.
The group led by Janejira Kittivorapart recorded only 396 discrepancies among more than 544 thousand tests. This corresponds to 0.15% of the total. These numbers already indicated how rare the problem is.
After removing samples that could be related to stem cell transplants, 198 truly conflicting cases remained.
Among them, only one showed the B(A) phenotype. And, in the cohort of donors, the discrepancy rate was even lower, at 0.03%.
Additionally, only two people from this group exhibited the same variation.
New Blood Type? How the B(A) Phenotype Works
The B(A) is a very specific alteration within the ABO system. The blood is classified as type B. However, mutations influence the action of the enzyme that adds antigens to red blood cells.
Due to these changes, the activity resembles that of type A, even though at a low intensity.
In the three observed cases, scientists found four novel mutations in the ABO gene. These mutations had never been mentioned before and modify the behavior of the enzyme.
Conventional tests may not detect the small level of antigen A present.
Therefore, the study serves as a warning for health professionals. Standard typing may fail in exceptional circumstances, and genetic analyses become important when laboratory results do not match.
What the Blood Type Finding Represents
The rarity of the phenotype does not diminish its impact. On the contrary, it reinforces that human blood goes beyond the most widespread classifications.
Understanding these small variations helps avoid transfusion incompatibilities and provides support in complex clinical situations.
Moreover, the study highlights that the field of hematology is vast. Beyond the ABO and Rh divisions, there are more than 45 recognized blood groups.
Each of them presents distinct characteristics that influence how blood is classified.
Other recent findings confirm this scenario. In 2024, researchers solved a five-decade doubt by identifying a new blood group system in a sample from 1972.
Already in 2025, French specialists announced the “Gwada-negative,” considered the rarest type ever recorded and present only in one woman from the island of Guadeloupe.
She is the only person compatible with herself.
These findings show how there are still open questions in this field. Future studies should explain how the newly identified mutations interfere with the structure of the enzyme involved in the ABO system.
With information from Revista Galileu.

-
-
-
3 people reacted to this.